January 2015 | eNews Patients with chronic lymphocytic leukemia (CLL) can live for several years—on average, over half of patients are alive five years after diagnosis. The... | [more]
Welcome to Dana-Farber/Harvard Cancer CenterDana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, and Massachusetts General Hospital.
Funded by a grant from the National Cancer Institute, we have joined these seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal -- to find new and innovative ways to combat cancer.
- Seminars in Oncology: "Identification of the Genetic Network that Prevents Genome Instability" Posted: 03-26-15
- New from the Health Communication Core: Improve your website’s visibility Posted: 03-23-15
- Seminars in Oncology: "An Epigenetic Switch Linking Inflammation to Cancer and the Use of Metformin as an Anti-Cancer Drug" Posted: 03-18-15
Latest Cancer News
January 2015 | eNews The NIH continues to recognize DF/HCC as a leader in cancer research by awarding funding to a number of our research initiatives. Recently, this... | [more]
January 2015 | eNews Umar Mahmood, MD, PhD (MGH), a radiologist, and Andrew Chan, MD, MPH (MGH), a gastroenterologist, have worked in both colon cancer... | [more]